Erb, Michael A.
Scott, Thomas G.
Li, Bin E.
Xie, Huafeng
Paulk, Joshiawa
Seo, Hyuk-Soo
Souza, Amanda
Roberts, Justin M.
Dastjerdi, Shiva
Buckley, Dennis L.
Sanjana, Neville E.
Shalem, Ophir
Nabet, Behnam
Zeid, Rhamy
Offei-Addo, Nana K.
Dhe-Paganon, Sirano
Zhang, Feng
Orkin, Stuart H.
Winter, Georg E.
Bradner, James E.
Article History
Received: 22 May 2016
Accepted: 3 February 2017
First Online: 1 March 2017
Competing interests
: J.E.B. is now an employee, shareholder, and executive of Novartis Pharmaceuticals; G.E.W. is a consultant for C4 Therapeutics; and N.E.S., O.S. and F.Z. are inventors on a patent application related to the CRISPR screening technology.
: The authors declare no competing financial interests.